Navigation Links
Can a standard vision test predict nighttime driving performance?
Date:4/10/2012

Rockville, Md. Just because a driver has passed the motor vehicle administration's vision test may not mean he or she is safe to drive. A recent study found that the frequency and distance at which drivers with moderate levels of blurred vision and cataracts recognize pedestrians at night was severely reduced, even when the drivers have passed the required vision test.

"Optical blur and cataracts are very common and lots of people with these conditions continue to drive," said author Joanne Wood of the School of Optometry and Vision Science and Institute of Health and Biomedical Innovation at Queensland University of Technology. "The aim of our study was to better understand how these visual conditions affect the ability to recognize and respond to roadside pedestrians at nighttime, and we also wanted to see if certain types of pedestrian clothing could improve the ability of a driver to recognize pedestrians at night, even when the driver had some level of visual loss."

In the study, Even moderate visual impairments degrade drivers' ability to see pedestrians at night, published in the Investigative Ophthalmology & Visual Science journal, 28 young adult licensed drivers who satisfied the minimum Australian driver's licensing criteria of 20/40 or better vision were used to measure a driver's ability to recognize pedestrians.

The participants drove at night on a closed road circuit wearing simulated refractive blur and cataract lenses. The pedestrians wore one of three different type of clothing: all black; all black with a reflective vest; and all black with reflectors on their wrists, elbows, ankles, knees, shoulders and waist to create a perception of human movement, known as biomotion. Sixteen of the 28 participants were asked to detect the pedestrian against simulated headlight glare.

Findings demonstrated that cataracts are significantly more disruptive than blurred vision. Drivers with simulated blurred vision recognized that a pedestrian was present 52.1% of the time and those with simulated cataracts recognized pedestrians only 29.9% of the time. The research team found that pedestrians wearing the reflective strips to create the biomotion condition were much more visible to drivers (82.3% of the time) than those wearing all black (13.5% of the time). Whether glare was present or not, none of the drivers with simulated cataracts recognized the pedestrian wearing black.

The results also show how these impairments reduce the distances at which drivers first recognize the presence of pedestrians at night. In the experiment, drivers with normal vision recognized pedestrians at longer distances: on average 3.6 times longer than drivers with blurred condition and 5.5 times longer than drivers with cataract conditions.

According to the researchers, the results have important implications and suggest that in order to maximize drivers' ability to see pedestrians from a safe distance, they should wear their optimum optical corrective lenses and cataract surgery should be performed early enough to avoid potentially dangerous driving conditions.

"Future studies should further explore the impact of uncorrected refractive error, cataracts and other forms of visual impairment on driving performance and safety as well as determine the value of some relatively new ways to measure visual abilities, such as straylight testing and contrast sensitivity," suggests Wood. "It is possible that measuring only visual acuity does not provide us with the best way to determine who is safe to drive."


'/>"/>

Contact: Katrina Norfleet
knorfleet@arvo.org
240-221-2924
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Related medicine news :

1. Job injuries among youth prompt calls for better safety standards
2. USF Healths center for training and evaluating health professionals sets standards for quality care
3. Weight-Loss Surgeries May Beat Standard Treatments for Diabetes
4. Novel drug in pill form safer than standard approach to treat blocked lung blood vessels
5. Fox Chase Cancer Center leads efforts to establish national standards for survivorship care
6. Standardized outcome measures proposed for asthma clinical research
7. CT colonography shown to be comparable to standard colonoscopy
8. New procedure bests standard of care for fixing damaged cartilage
9. Standard treatments for head and neck cancer less effective in HIV-positive patients
10. Counterfeit and substandard anti-malaria drugs threaten crisis in Africa, experts warn
11. Prospective surveillance model emerges as standard of care for breast cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... 2017 , ... Dr. Kiya Green, a periodontist in Matthews, ... treatments, including crown lengthening and gum reduction surgery, with or without ... procedures to help patients improve their oral health, reduce gummy smiles and achieve ...
(Date:5/22/2017)... ST. PAUL, Minn. (PRWEB) , ... May 22, 2017 , ... ... one young man’s experience learning to live with Bipolar 1. Donald Rodriguez takes readers ... icy mountain in Alaska in the dead of winter and to a dark place ...
(Date:5/22/2017)... Francisco, CA (PRWEB) , ... May 22, 2017 ... ... will sponsor a program on Wellocity to empower WeightZone Factor members to ... their medications, and get an excellent health education, all on their mobile phones. ...
(Date:5/21/2017)... ... May 19, 2017 , ... HealthSmart, the largest ... James (Jim) Vertino as Chief Information Officer (CIO). He will be joining HealthSmart ... innovation and business performance. He defines strategic roadmaps by reimagining business processes—bridging the ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... Pot. Reefer. ... find it, review it, and share its attributes like never before. More than a ... to connect cannabis enthusiasts to stores, strains, products – and for the first time ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... May 10, 2017  The Corporate Whistleblower Center ... of sleep therapy clinics to call us anytime ... clinic is involved in a substantial scheme to ... hearing from an employee of a medical equipment ... scheme to provide medical practice groups with extra ...
(Date:5/9/2017)... 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral ... Intellectual Property Office has granted Oramed a patent ... Exenatide". The patent covers Oramed,s invention of an ... is an incretin hormone that stimulates the secretion ...
Breaking Medicine Technology: